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Arsenic that is naturally present in soil can be
mobilized and transported, leading to
increased concentrations of As in aquifers that
are sources of drinking water (Harvey et al.
2002). The largest contemporary known mass
exposure to As is occurring due to the con-
sumption of tube-well water throughout the
Ganges-Brahmaputra Delta in Bangladesh and
India. In Bangladesh alone, this exposure is
affecting approximately 25–30 million resi-
dents. Our survey of roughly 6,000 contiguous
wells in Araihazar, Bangladesh, the region of
interest in the current study, reported well-
water As concentrations ranging from < 5 to
860 µg/L (van Geen et al. 2002). This range
greatly exceeds the maximum contaminant
level of 10 µg/L promulgated by the U.S.
Environmental Protection Agency (EPA 2001)
and the World Health Organization (WHO
2004), as well as the Bangladesh standard of
50 µg/L. 
Individuals chronically exposed to As are
at increased risk for various cancers, including
cancers of the skin, bladder, lung, and liver.
Chronic As exposure is also a risk factor for
stroke (Chiou et al. 1997), ischemic heart dis-
ease (Hsueh et al. 1997), and neurologic con-
sequences in adults and children (Wasserman
et al. 2004). In addition, inorganic arsenic
(InAs) has long been considered to be a
teratogen in multiple mammalian species
(Shalat et al. 1996; Wlodarczyk et al. 2001).
The biomethylation of InAs generates
mono- and dimethyl arsenic species [mono-
methylarsonic acid (MMA) and dimethy-
larsinic acid (DMA), respectively; Figure 1]
which are more readily excreted than InAs
(Vahter and Marafante 1987). Individuals
whose urine contains relatively lower propor-
tions of DMA have been reported to be at
increased risk for skin and bladder cancers
(Chen et al. 2003a, 2003b; Hsueh et al. 1997;
Yu et al. 2000). Thus, methylation of InAs
has traditionally been considered to be a
detoxification pathway. However, a growing
literature of experimental studies indicates
that the trivalent methylated arsenic interme-
diates (MMAIII and DMAIII) may be more
toxic than InAsIII or any of the pentavalent
intermediates (Ahmad et al. 1999; Lee et al.
1988; Nesnow et al. 2002; Styblo et al. 2002).
In humans, there is considerable inter-
individual variability in the proportions of
InAs, MMA, and DMA excreted in urine.
InAs and MMA are enzymatically methylated
via one-carbon metabolism, a biochemical
pathway dependent on folate for recruitment
of methyl groups. One-carbon metabolism
also requires vitamins B12 (cobalamin) and B6
as cofactors (Figure 2). Not surprisingly,
animal studies have suggested that folate
nutritional status may influence As metabo-
lism. For example, dietary folate deficiency
(Spiegelstein et al. 2005) and/or dietary
methyl donor deficiency significantly
decreased total urinary As excretion, mainly
due to lower DMA excretion; these diets also
gave rise to increased retention of As in tis-
sues, particularly in the liver and lungs (Tice
et al. 1997; Vahter and Marafante 1987).
These studies provided experimental evidence
that the well-characterized nutritional regula-
tion of one-carbon metabolism can inﬂuence
As methylation and excretion. 
The evidence for nutritional regulation of
As methylation and excretion in humans is
limited. In a study of 11 families in Chile,
Chung et al. (2002) reported intrafamily asso-
ciations in arsenic methylation. Although the
correlation for InAs/(MMA+DMA) between
father and mother was low (r = 0.18), adjust-
ment for folate or homocysteine increased the
correlation substantially (r = 0.33 and 0.55,
respectively). The authors did not conclude
that there was a signiﬁcant effect of nutritional
factors on methylation, but the data were
highly suggestive (Chung et al. 2002). A case–
control study in West Bengal, India, using
dietary assessment, found a modest increase in
risk for arsenicosis skin lesions for individuals
within the lowest quintiles for dietary intake
of animal protein, calcium, fiber, and folate
(Mitra et al. 2004).
In the current study we tested the
hypothesis that nutritional regulation of one-
carbon metabolism, specifically folate nutri-
tional status, contributes to the interindividual
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Chronic exposure to arsenic is occurring throughout South and East Asia due to groundwater cont-
amination of well water. Variability in susceptibility to arsenic toxicity may be related to nutritional
status. Arsenic is methylated to monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA)
via one-carbon metabolism, a biochemical pathway that is dependent on folate. The majority of
one-carbon metabolism methylation reactions are devoted to biosynthesis of creatine, the precursor
of creatinine. Our objectives of this cross-sectional study were to characterize the relationships
among folate, cobalamin, homocysteine, and arsenic metabolism in Bangladeshi adults. Water
arsenic, urinary arsenic, urinary creatinine, plasma folate, cobalamin, and homocysteine were
assessed in 1,650 adults; urinary arsenic metabolites were analyzed for a subset of 300 individuals.
The percentage of DMA in urine was positively associated with plasma folate (r = 0.14, p = 0.02)
and negatively associated with total homocysteine (tHcys; r = –0.14, p = 0.01). Conversely, percent
MMA was negatively associated with folate (r = –0.12, p = 0.04) and positively associated with
tHcys (r = 0.21, p = 0.0002); percent inorganic arsenic (InAs) was negatively associated with folate
(r = –0.12, p = 0.03). Urinary creatinine was positively correlated with percent DMA (r = 0.40 for
males, p < 0.0001; 0.25 for females, p = 0.001), and with percent InAs (r = –0.45 for males,
p < 0.0001; –0.20 for females, p = 0.01). Collectively, these data suggest that folate, tHcys, and
other factors involved in one-carbon metabolism inﬂuence arsenic methylation. This may be partic-
ularly relevant in Bangladesh, where the prevalence of hyperhomocysteinemia is extremely high.
Key words: arsenic, arsenicosis, Bangladesh, creatinine, dimethylarsinic acid, folate, homocysteine,
hyperhomocysteinemia, micronutrient deficiency, monomethylarsonic acid, one-carbon metabo-
lism, S-adenosylmethionine, vitamin B12, well water. Environ Health Perspect 113:1683–1688
(2005). doi:10.1289/ehp.8084 available via http://dx.doi.org/ [Online 21 July 2005]variability observed in InAs methylation. We
conducted a cross-sectional study to assess the
relationships among plasma total homocys-
teine (tHcys), total cysteine (Cys), folate, and
cobalamin concentrations and As metabolism
in adults residing in Araihazar, Bangladesh. 
Methods
The data presented are from the Nutritional
Inﬂuences on Arsenic Toxicity (NIAT) study,
an ongoing study on nutritional inﬂuences on
arsenic metabolism. The NIAT study works in
collaboration with a larger multidisciplinary
program by health, earth, and social scientists
from Columbia University and Bangladesh
(the Columbia University Superfund Basic
Research Program), the National Institute of
Preventive and Social Medicine, and Dhaka
University. The centerpiece of the public
health research is a prospective cohort study,
Health Effects of Arsenic Longitudinal Study
(HEALS), of 12,000 adults exposed to a wide
range of water As concentrations, from which
the current sample is derived. 
Study region. Bangladesh is a nation of
roughly 124 million people inhabiting an area
of 145,000 km2. It is divided into 64 districts,
each of which is divided into 10–50 adminis-
trative units or Thanas. The study site is in
Araihazar, one of 464 Thanas in Bangladesh,
and is a 25-km2 region approximately 30 km
east of Dhaka. The study site was chosen
because a) it is known to have a wide range of
As concentrations in the drinking water, per-
mitting dose–response analyses and b) it is
within a reasonable commuting distance from
Dhaka. Socioeconomic data indicate that this
region is not particularly poor by Bangladeshi
standards.
Eligibility criteria/participant recruitment/
ethics. The HEALS cohort study includes a
random sample of 11,746 married men and
women between 20 and 65 years of age who
were recruited between September 2000 and
May 2002 and are followed at 2-year intervals
(Ahsan et al., in press). This study only
included married couples to minimize the
likelihood of loss to follow-up due to a
change of residence after marriage. Centered
around visits of one of the investigators
(M.V.G.), a subset of 1,650 of these cohort
study participants were consecutively enrolled
in the present study. We further selected
300 of these 1,650 participants to measure
urinary arsenic metabolites. This subset of
participants was selected to be representative
of the study population for total urinary As;
the subset excluded those identiﬁed as being
cobalamin deficient (plasma cobalamin con-
centrations < 185 pmol/L). Oral informed
consent was obtained by our Bangladeshi ﬁeld
staff physicians, who read an institutional
review board approved assent form to the
study participants. Ethics approval was
obtained from the Institutional Review Board
of Columbia Presbyterian Medical Center and
the Bangladesh Medical Research Council,
and informed consent was obtained by our
Bangladeshi ﬁeld staff physicians.
Plasma collection and handling. We
obtained plasma samples for tHcys, folate, and
total cobalamin by venipuncture after the par-
ticipant had been sitting for 10–15 min for an
interview. Blood was collected into EDTA-con-
taining tubes and immediately placed in
IsoRack cool packs (Brinkmann Instruments,
Westbury, NY) designed to maintain samples
at 0°C for > 6 hr. Within 4 hr, samples were
transported in hand-carried coolers containing
additional ice packs to our local laboratory situ-
ated in our three-story ﬁeld clinic in Araihazar.
Samples were centrifuged at 4°C and plasma
separated from the cells. Plasma was then stored
in aliquots at –80°C and shipped frozen on dry
ice to Columbia University for analysis.
Measures of arsenic exposure. We ana-
lyzed well-water arsenic concentrations as part
of a comprehensive well survey before the
onset of the cohort study. The actual well-
water arsenic concentration was labeled onto
each well, with signs indicating safety or dan-
ger, and many study participants subse-
quently switched wells to reduce exposure
(van Geen et al. 2002); therefore, well-water
arsenic did not always strictly represent cur-
rent arsenic exposure. However, we do not
believe that this led to significant exposure
misclassiﬁcation, as the duration of drinking
water from the surveyed well greatly exceeded
the duration of drinking water from an alter-
nate well. In the analyses pertaining to folate
and tHcys concentrations, any potential expo-
sure misclassification would only bias to the
null. Furthermore, we collected urine samples
for urinary arsenic measurements on the same
visit that the plasma samples were collected.
Well-water and urinary As provide two dif-
ferent estimates of As exposure. Although well-
water As provides a direct measure of exposure
that is uninﬂuenced by in vivo metabolism, it
does not take into account the amount of
water consumed or the accumulated body bur-
den. Urinary As, traditionally considered a
marker of recent exposure, may more closely
reﬂect the body burden of As in a given indi-
vidual because a) it receives contributions
from tissue stores and b) it is more strongly
associated with skin lesions than is well-water
As (Ahsan et al. 2000). Urinary As concentra-
tions are heavily influenced by variations in
hydration status, as indicated by the associa-
tion between total urinary As and urinary cre-
atinine concentrations (r = 0.58, p < 0.0001,
N = 1,650); thus, urinary creatinine must be
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Figure 1. Arsenic metabolic pathway. Arsenate is reduced to arsenite in a reaction thought to be depen-
dent on GSH or other endogenous reductants. Abbreviations: GSH, glutathione; GSSG, glutathione disul-
fide; GST, glutathione-S-transferase; SAH, S-adenosylhomocysteine; SAM, S-adenosylmethionine; TR,
thioredoxin reductase. Arsenite then undergoes an oxidative methylation, with SAM as the methyl donor,
forming MMAV and SAH. MMAV is reduced to MMAIII before a subsequent oxidative methylation step
yielding DMAV and SAH. Little is known regarding in vivo reduction of DMAV to DMAIII. Enzymes capable
of catalyzing the illustrated reactions include Cyt19 (Lin et al. 2002), arsenite methyltransferase and methy-
larsonite methyltransferase (two activities of one enzyme) (Zakharyan et al. 1995), and MMAV reductase
(also known as GST-Ω) (Zakharyan et al. 2001). included as a separate variable in the urinary As
analyses. Because animal studies suggest that
impaired one-carbon metabolism incurred by
methyl-deficient diets decreases total urinary
arsenic by up to 20–30% (Spiegelstein et al.
2003, 2005; Tice et al. 1997; Vahter and
Marafante 1987), both urine As and well water
As were included in the analyses. 
Total urinary As. We measured total uri-
nary As concentrations by graphite furnace
atomic absorption spectrometry using the
Analyst 600 graphite furnace system (Perkin
Elmer, Shelton, CT) in the Columbia
University Trace Metals Core Lab, essentially
as previously described (Nixon et al. 1991).
Our laboratory participates in a quality control
program coordinated by Philippe Weber at
the Quebec Toxicology Center in Quebec,
Canada. During the course of this study, intra-
class correlation coefﬁcients between our labo-
ratory’s values and samples calibrated at the
Quebec laboratory were 0.99. Urinary creati-
nine concentrations were analyzed by a colori-
metric Sigma Diagnostics Kit (Sigma, St.
Louis, MO). 
Urinary arsenic metabolites. Urinary
arsenic metabolites were speciated for 300 par-
ticipants using a method adapted from
Heitkemper (Vela et al. 2001). This method
employs HPLC separation of arsenobetaine
(AsB), arsenocholine (AsC), arsenate, arsenite,
MMA, and DMA, followed by detection by
inductively-coupled mass spectrometry (ICP-
MS). We calculated the percentages of InAs,
MMA, and DMA after subtracting AsC and
AsB from the total. In most cases, AsC and
AsB were nondetectable.
Plasma folate and cobalamin. We ana-
lyzed folate and cobalamin in 1648 plasma
samples by radioimmunoassay (Quantaphase
II, Bio-Rad Laboratories, Richmond CA), as
previously described (Gamble et al. 2005). 
Plasma homocysteine and cysteine concen-
trations. We measured plasma tHcys and Cys
concentrations in 1644 plasma samples by
HPLC with ﬂuorescence detection according
to the method described by Pfeiffer et al.
(1999), as described previously (Gamble et al.
2005). The within-day and between-day
coefficients of variation for tHcys were 5%
and 8%, respectively.
Statistical analyses. We calculated
descriptive statistics for characteristics of the
study sample separately by sex. Because we
expected the distributions to be non-normal,
sex differences in quantitative variables were
tested using the Wilcoxon rank-sum test that
requires no distribution assumption. We used
chi-square tests to test for sex differences in
categorical variables.
We used linear regression analyses to
examine associations. Because As exposure
might potentially inﬂuence plasma folate and
tHcys concentrations, we explored the associ-
ations between these variables in the
1,650 samples. In sequential regression analy-
ses on the subset of 300 participants with uri-
nary arsenic metabolite data, we examined
determinants of percentages of InAs (%InAs),
MMA(%MMA), and DMA (%DMA). 
Because tHcys, folate, and cobalamin in
plasma, and water arsenic, urine arsenic, and
urine creatinine have skewed distributions, we
used log-transformation to achieve approxi-
mately symmetric distributions. In prelimi-
nary analyses, water arsenic, age, sex, cigarette
smoking, and betelnut use were found to be
associated with urinary arsenic metabolites
and were therefore included in our regression
models as potential confounding variables.
Results
Characteristics of the population. The general
characteristics of the NIAT study sample have
been previously described in detail (Gamble
et al. 2005). Out of 1,650 participants,
973 were women and 677 were men. The
mean ages for women and men were 34.6 ±
8.8 and 42.2 ± 9.8 years, and body mass
indices were 20.2 ± 3.2 and 19.4 ± 3.0, respec-
tively. Betelnut use was practiced by 30% of
women and 40% of men, whereas 6% of
women and 76% of men smoked cigarettes.
tHcys, folate, and cobalamin ﬁndings. We
recently reported a high prevalence of hyper-
homocysteinemia, particularly among males
(63% ≥ 11.4 µM) in this study population
(Gamble et al. 2005). Folate and cobalamin
nutritional status accounted for 15% and 5%,
respectively, of the variability in tHcys.
Arsenic exposure. As is shown in Table 1,
urinary As concentrations, expressed in
micrograms per liter, did not differ between
males and females. However, when adjusted
for urinary creatinine, as is routinely done to
correct for the effects of hydration, males had
significantly lower As concentrations than
females. This divergence is attributable to sig-
niﬁcant sex differences in urinary creatinine,
which is related to lean body mass (Schutte
et al. 1981). Well-water As concentrations
ranged from 0.1 µg/L to 650 µg/L, with 82%
Folate, homocysteine, and arsenic in Bangladesh
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Figure 2. Overview of one-carbon metabolism. 1. Dietary folates are reduced to dihydrofolate (DHF) and
tetrahydrofolate (THF) by dihydrofolate reductase. 2. The β-carbon of serine is transferred to THF by serine
hydroxymethyltransferase, forming 5,10-methenyl-THF and glycine. 3. At a major branch point between
transmethylation reactions and nucleotide biosynthesis, 5,10-methenyl-THF can be reduced to 5,10-meth-
ylene-THF and further reduced to 5-methyl-THF by 5,10-methylene-THF reductase. 4. In a reaction cat-
alyzed by the vitamin B12-containing enzyme, methionine synthetase, the methyl group of 5-methyl-THF is
transferred to homocysteine, generating methionine and regenerating THF. 5. Methionine adenosyl-
transferase activates methionine to form S-adenosylmethionine (SAM). 6. SAM serves as a universal
methyl donor for numerous acceptors, including predominantly guanidinoacetate (GAA), but also DNA,
arsenic, and others, in reactions that involve a number of methyltransferases. 7. The by-product of these
methylation reactions, S-adenosylhomocysteine (SAH), is hydrolyzed to generate homocysteine. SAH is a
potent inhibitor of most SAM-dependent methylations. 8. Homocysteine is either used to regenerate
methionine or is directed to the transsulfuration pathway through which it is ultimately catabolized. 9. The
transsulfuration pathway is also responsible for glutathione (GSH) biosynthesis.
Table 1. Sex differences in urinary creatinine and
urinary arsenic when expressed per gram creati-
nine (mean ± SD).
Females Males
(n = 961) (n = 675) p-Value
Urinary 134 ± 120 133 ± 137 0.26
arsenic (µg/L)
Urinary 57 ± 41 70 ± 53 < 0.0001
creatinine (mg/dL)
Arsenic/g 284 ± 226 194 ± 179 < 0.0001
creatinineof wells having concentrations > 10 µg/L and
63% > 50 µg/L.
Influence of arsenic exposure on folate,
tHcys and Cys. Among the entire sample
(n = 1,650), water arsenic concentrations were
significantly associated with plasma folate
(r = –0.13, p < 0.0001), tHcys (r = 0.05,
p = 0.03), and Cys (r = 0.13, p < 0.0001).
Although total urinary arsenic (micrograms per
gram creatinine) was also negatively associated
with plasma folate (r = –0.15, p < 0.0001), it
was not associated with tHcys or Cys
(r = –0.03, p = 0.29; r = –0.03, p = 0.23 ).
Folate deﬁciency may inﬂuence urinary creati-
nine concentrations because the synthesis of
creatine, the precursor of creatinine, accounts
for approximately 75% of folate- and S-adeno-
sylmethionine (SAM)-dependent transmethy-
lation reactions (Figure 2, reaction 6; Mudd
et al. 1975). Thus, we sought to rule out the
possibility that the inverse association between
plasma folate and urinary As per gram creati-
nine might be due to an association between
plasma folate and urinary creatinine. Indeed,
plasma folate concentrations were positively
correlated with urinary creatinine for males
(r = 0.083, p = 0.0308) (Gamble et al. 2005).
Urinary arsenic concentrations (micrograms
per liter) were negatively associated with
plasma folate (r = –0.13, p < 0.0001), even
when not adjusted for urinary creatinine.
tHcys, folate, cobalamin, and urinary
arsenic metabolites. Urinary As metabolites
measured in a subset of 300 study participants
showed a wide interindividual variability in
arsenic methylation capacity. For example,
the percentage of total urinary As present as
DMA (%DMA) ranged from 20 to 90%,
with the majority falling between 50 and 80%
(Figure 3). In addition, methylation capacity
differed by sex: on average, females had a
higher %DMA than males (72.2 ± 10.4 vs.
69.7 ± 7.7 %DMA, respectively, p = 0.0012)
and a lower %MMA (11.5 ± 4.8 vs. 15.5 ± 5.2
%MMA, respectively, p < 0.0001). The %InAs
did not differ by sex (16.3 ± 10.1 vs.
14.7 ± 5.5, p = 0.60). The sex differences per-
sisted in regression analyses for %DMA and
%MMA after adjustment for other covariates
including age and water arsenic (data not
shown). Although age was not significantly
associated with %DMA, it was positively asso-
ciated with %MMA and negatively associated
with %InAs (r = 0.29, p < 0.0001, and r =
–0.24, p < 0.0001, respectively). Although
only 12 of these 300 participants had arsenic-
related skin lesions, the presence of skin
lesions was associated with higher %MMA
(18.5 ± 5.2 vs. 13.1 ± 5.3, p = 0.0016) and
with lower %DMA (66.6 ± 9.1 vs. 71.3 ± 9.3,
p = 0.0518). These ﬁndings have recently been
confirmed in a much larger sample of the
HEALS cohort study (data not shown).
As hypothesized, %DMA was positively
associated with plasma folate and negatively
associated with plasma tHcys (Table 2).
Conversely, %MMA was negatively associated
with plasma folate and positively associated
with tHcys. Although %InAs was also nega-
tively associated with folate, the association
with tHcys was not significant. In addition,
plasma Cys concentrations were negatively
correlated with %InAs and positively corre-
lated with %MMA. Plasma cobalamin con-
centrations were not correlated with arsenic
metabolites.
Due to the clear biochemical link between
creatine biosynthesis and SAM-dependent
transmethylation reactions (Figure 2, reaction
6), the expression of urinary As per gram crea-
tinine might potentially confound the associa-
tions with arsenic metabolites. To explore this
possibility, we examined the association
between urinary creatinine and urinary arsenic
metabolites. We observed that urinary creati-
nine was strongly and positively associated
with %DMA for both males and females and
negatively associated with %InAs and with
%MMA for females (Table 3). These associa-
tions remained highly signiﬁcant after control-
ling for other covariates including body weight,
age, and water arsenic. Furthermore, the asso-
ciations between As metabolites and folate or
tHcys became nonsigniﬁcant when urinary cre-
atinine was included in regression analyses. 
We previously reported that cigarette smok-
ing and betelnut use are both negative predic-
tors of plasma folate and positive predictors of
tHcys (Gamble et al. 2005). Betelnut use also
proved to be a signiﬁcant predictor of %MMA,
even after adjusting for covariates including sex,
cigarette smoking, water arsenic, urinary creati-
nine, and plasma folate (p = 0.03).
Discussion
Our previous observation of a high prevalence
of hyperhomocysteinemia in Araihazar,
Bangladesh (Gamble et al. 2005) afforded us a
suitable setting in which to assess the potential
impact of hyperhomocysteinemia and folate
deﬁciency on arsenic metabolism in a human
population. Although cobalamin concentra-
tions were not significantly associated with
arsenic metabolism, this ﬁnding was not unex-
pected because a) cobalamin deﬁciency is rela-
tively rare in this region, where vegetarianism is
uncommon, and b) cobalamin-deﬁcient partic-
ipants were excluded from the study on arsenic
metabolites. Thus, the results of this study do
not rule out the possibility that cobalamin
deﬁciency may inﬂuence arsenic methylation.
Gamble et al.
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Figure 3. Frequency distribution for As metabolites. Interindividual variability across 300 participants for
arsenic metabolites in urine.
Table 2. Spearman correlation coefficients for As
metabolites versus plasma folate, tHcys, and
cobalamin for 300 participants.
%InAs %MMA %DMA
tHcys (µM) 0.06 0.21# –0.14**
Cysteine (µM) –0.11* 0.16** 0.01
Folate (nM) –0.12* –0.12* 0.14*
Cobalamin (pM) –0.06 –0.002 0.04
*p < 0.05. **p < 0.01. #p < 0.001. 
Table 3. Spearman correlation coefficients for As
metabolites versus urinary creatinine.
%InAs %MMA %DMA
Males (n = 136) –0.45## –0.13 0.40##
Females (n = 164) –0.20**a –0.16* 0.25**
Total (n = 300) –0.32## –0.09 0.30##
aCorrelation between urinary creatinine and %InAs differ
by sex (p = 0.014). *p < 0.05. **p < 0.01. ##p < 0.0001. In general, although the effect sizes were rela-
tively small, the associations between As
methylation and folate and tHcys were as pre-
dicted; however, a few points are of particular
interest. First, the observation that folate is
negatively (and equally) associated with both
%InAs and %MMA implies that adequate
folate nutritional status is required for both
the first and the second methylation steps.
This may be of clinical relevance because a
growing body of evidence links increased risk
for adverse health outcomes to higher %MMA
and reduced risk with higher %DMA in urine
(Chen et al. 2003a, 2003b; Hsueh et al. 1997;
Yu et al. 2000).
A second ﬁnding of interest is our observa-
tion that tHcys is not associated with %InAs
but is positively associated with %MMA
(Table 2). In one-carbon metabolism, all SAM-
dependent methylation reactions yield the
methylated product and S-adenosylhomocys-
teine (SAH; Figure 2, reaction 6). SAH is then
hydrolyzed to homocysteine in a reaction that is
readily reversible. Plasma SAH levels increase
linearly with even mild elevations in homocys-
teine levels (Yi et al. 2000). This is of particular
relevance because SAH is a potent product
inhibitor of most transmethylation reactions (Yi
et al. 2000), including those of arsenic
(De Kimpe et al. 1999). SAH binds tightly to
methyltransferases and is only removed if the
pathway is pulled forward by downstream
removal of tHcys, as might be achieved with
folate supplementation (Figure 2, reaction 4).
SAH is actually more crucial than SAM in reg-
ulating methylation reactions (Yi et al. 2000).
Thus, it is possible that the positive association
between tHcys and %MMA and negative asso-
ciation with %DMA may reﬂect inhibition of
the second methylation step by SAH. It is not
entirely clear why tHcys is not also positively
associated with %InAs. Perhaps because SAH
binds to the arsenic methyltransferase during
the first methylation step, it subsequently
inhibits the second methylation step. The
potential for folate supplementation to reverse
hyperhomocysteinemia and thereby facilitate
arsenic methylation is currently being tested in
a placebo-controlled double-blind folate supple-
mentation trial to folate deﬁcient participants. 
The amino acid Cys is produced from Hcys
as an intermediate in glutathione biosynthesis
(Figure 2, reaction 8). Consequently, Cys con-
centrations in plasma are positively correlated
with both tHcys and glutathione (GSH). Cys
has recently been reported to play a role in
redox cycling (Jones et al. 2004). Like glu-
tathione, Cys is capable of reducing pentavalent
AsV to AsIII in vitro (Celkova et al. 1996), and
this reduction is a prerequisite to methylation.
The observation that plasma Cys concentra-
tions are negatively associated with %InAs and
positively associated with %MMA suggests that
this capacity may be physiologically relevant.
However, we cannot rule out the possibility
that the observed associations are simply due to
a positive association between Cys and plasma
GSH. The complete lack of an association with
%DMA suggests that Cys (or possibly GSH)
does not similarly reduce MMAV to MMAIII to
facilitate the second methylation step.
A number of noteworthy observations
regarding urinary creatinine arose from this
study. The formation of creatine from methyla-
tion of guanidinoacetate has been estimated to
account for approximately 75% of transmethy-
lation reactions (Mudd and Poole 1975).
Creatine is a precursor of creatinine, and both
are synthesized and circulate at concentrations
proportional to muscle mass, which is generally
greater in males than females. Consequently,
urinary creatinine is also greater for males than
females (Barr et al. 2005; Gamble and Liu
2005). Because creatinine is excreted at a rela-
tively constant rate throughout the course of
the day, it is commonly used as a correction fac-
tor to adjust for variations in urine concentra-
tion. It is important to note, however, that this
adjustment introduces an artiﬁcial sex differ-
ence such that, using total urinary arsenic/g cre-
atinine as the exposure variable, males may
artiﬁcially appear to have a lower exposure than
females. This ﬁnding has particular relevance to
the ﬁeld of As toxicology because it has been
reported that males may be more susceptible
than females to arsenic toxicity (Chen et al.
2003a; Kristiansen et al. 1997) for two reasons.
First, creatinine adjustment causes males to
appear to have a lower exposure than females
(Table 1). Second, although speculative, it is
also possible that the increased susceptibility
among males is related to the fact that males
place higher demands on one-carbon metabo-
lism due to their greater muscle mass and asso-
ciated demands for creatine formation and
resultant higher tHcys (Brattstrom et al. 1994). 
The associations between the methylation
of As and urinary creatinine are quite remark-
able and intriguing. In this study, urinary crea-
tinine was the strongest predictor by far of
arsenic methylation. Particularly for males, the
effect sizes were more than double those of any
of the nutritional variables. There are a number
of plausible mechanisms which could explain
these associations: a) for reasons described
above, urinary creatinine may serve as a proxy
for one-carbon “metabolic rate”; b) urinary cre-
atinine is a known proxy for muscle mass,
which could have some unknown impact on As
methylation; c) urinary creatinine is inﬂuenced
by dietary protein intake, which inﬂuences one-
carbon metabolism in-so-far as it provides a
source of methionine; and d) urinary creatinine
is inﬂuenced by renal function, which, for rea-
sons that remain unclear, is a primary determi-
nant of tHcys concentrations (Arnadottir et al.
1996; Wollesen et al. 1999). Any of these
mechanisms acting either independently or in
concert may play a role in determining what
fraction of InAs is methylated.
Like cigarette smoking and betelnut use
(Gamble et al. 2005), total urinary As and
well-water As were found to be negatively asso-
ciated with plasma folate. Because folate is
highly prone to oxidative degradation, and
because there is a substantial basic literature
indicating that exposure to As induces oxida-
tive stress, it is possible that this observation is
attributable to As-induced oxidative degrada-
tion of folate. The positive associations
between well-water As and tHcys and Cys
likely follow from their metabolic interrelations
with folate.
Alternatively, it has been postulated that
increased demands on one-carbon metabolism
for the methylation of As in those chronically
exposed to As-contaminated drinking water
may deplete the methyl donor pool (Mass and
Wang 1997). We have not measured the
hepatic methyl donor pool, nor is it entirely
clear from our understanding of folate and
one-carbon metabolism what effect depletion
of the methyl donor pool would have on
plasma folate concentrations. If one were to
assume that methyl depletion would increase
folate turnover, then plasma folate concentra-
tions would be reduced. This is another
potential explanation for the observation that
well water As and urinary As were negatively
associated with plasma folate, but determina-
tion of the mechanism underlying this obser-
vation will require additional study. 
In conclusion, the results of this cross-
sectional study suggest that adequate folate
nutritional status facilitates both the ﬁrst and
second methylation steps, resulting in excre-
tion of lower proportions of InAs and MMA
and higher DMA. Conversely, individuals
with hyperhomocysteinemia have a reduced
ability to methylate MMA to generate DMA.
As evidence has accrued linking increased risk
for various adverse health outcomes to higher
%MMA and lower %DMA in urine, it
appears that hyperhomocysteinemia may rep-
resent a modiﬁable risk factor for arsenic toxi-
city. This may be particularly important in
Bangladesh, where the incidence of hyperho-
mocysteinemia is extremely high (Gamble
et al. 2005). Elucidation of the mechanism(s)
underlying the relationship between urinary
creatinine and arsenic methylation deserves
further investigation.
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